- Home
- HOVR vs ANL Comparison
HOVR vs ANL Comparison
Compare HOVR & ANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | HOVR | ANL |
|---|---|---|
| Founded | 2013 | 2004 |
| Country | Canada | Cayman Islands |
| Employees | N/A | N/A |
| Industry | Blank Checks | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 80.5M | 350.9M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | HOVR | ANL |
|---|---|---|
| Price | $1.88 | $8.82 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $10.33 | ★ $16.00 |
| AVG Volume (30 Days) | ★ 500.2K | 218.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.35 | $0.88 |
| 52 Week High | $4.18 | $12.09 |
Technical Indicators
Market Signals| Indicator | HOVR | ANL |
|---|---|---|
| Relative Strength Index (RSI) | 47.59 | 56.62 |
| Support Level | $1.69 | $1.37 |
| Resistance Level | $1.90 | $10.15 |
| Average True Range (ATR) | 0.15 | 0.94 |
| MACD | 0.00 | -0.30 |
| Stochastic Oscillator | 44.40 | 59.18 |
Price Performance
Historical ComparisonAbout HOVR New Horizon Aircraft Ltd.
New Horizon Aircraft Ltd is an aerospace Original Equipment Manufacturer that is designing and building a next-generation hybrid electric vertical take-off and landing aircraft for the regional air mobility market. Its aircraft will offer a more efficient way to move people and goods at a regional scale, help to connect remote communities, and advance its ability to deal with an increasing number of climate-related natural disasters such as wildfires, floods, and droughts. The company aims to deliver a hybrid electric 7-seat aircraft, called the Cavorite X7, that can take off and land vertically like and helicopter.
About ANL Adlai Nortye Ltd.
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.